Per the US DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the US DoD only publicly reports contracts valued at $6.5 million USD or greater.
Principle Contractor: Novartis Vaccines and Diagnostics, Incorporated
Date Reported: 1/30/2012
Department: Defense Advanced Research Projects Agency
Contract Details: Novartis Vaccines and Diagnostics, Inc., Cambridge, Mass., is being awarded a $14,189,4020 technology investment agreement. The goal of this agreement is for Novartis to perform a research and development program designed to develop a self-replicating RNA vaccine platform. Work will be performed in Cambridge, Mass. Work is expected to be completed by November 2015. The Defense Advanced Research Projects Agency is the contracting activity (HR0011-12-3-0001).
Total Contract Value: $14,189,402
View More Contracts by Novartis Vaccines and Diagnostics, Incorporated
TOTALS by YEAR:
TOTALS by DAY:
• United States Army
• United States Navy
• United States Air Force
• Defense Logistics Agency
• Special Operations COMmand (SOCOM)
• Transportation Command
• Defense Advanced Research Projects Agency
• Missile Defense Agency
• National Geospatial-Intelligence Agency
• Defense Information Systems
• Defense Finance and Accounting
• Defense Commissary Agency
• Defense Media Activity
• Defense Threat Reduction Agency
©2014 www.MilitaryIndustrialComplex.com • Content ©2006-2014 MilitaryIndustrialComplex.com • All Rights Reserved
Contract descriptions and monetary totals are supplied by the US DoD and we do not maintain exclusive ownership of that content.
All else is © MilitaryIndustrialComplex.com. Contract Details and their Total Values represented throughout this website are updated daily (M thru F)
pending the release of DoD information after 5PM ET. This website is not officially endorsed nor affiliated with any political party, corporation or the US DoD.